Joseph Makhema

14.0k total citations
37 papers, 1.4k citations indexed

About

Joseph Makhema is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Joseph Makhema has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 22 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Joseph Makhema's work include HIV/AIDS Research and Interventions (26 papers), HIV Research and Treatment (22 papers) and HIV/AIDS drug development and treatment (10 papers). Joseph Makhema is often cited by papers focused on HIV/AIDS Research and Interventions (26 papers), HIV Research and Treatment (22 papers) and HIV/AIDS drug development and treatment (10 papers). Joseph Makhema collaborates with scholars based in United States, Botswana and South Africa. Joseph Makhema's co-authors include Max Essex, Ibou Thior, Shahin Lockman, Richard Marlink, Roger Shapiro, Poloko Kebaabetswe, Peter B. Gilbert, Sheri D. Weiser, William R. Wolfe and David R. Bangsberg and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Joseph Makhema

33 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Makhema United States 16 1.1k 507 429 358 175 37 1.4k
Kathleen Ragland United States 21 1.2k 1.1× 382 0.8× 510 1.2× 719 2.0× 233 1.3× 27 1.8k
Karl‐Günter Technau South Africa 24 1.4k 1.2× 673 1.3× 471 1.1× 396 1.1× 305 1.7× 80 1.6k
Ida Viho Ivory Coast 25 1.4k 1.2× 490 1.0× 711 1.7× 616 1.7× 254 1.5× 42 1.6k
John Idoko Nigeria 21 771 0.7× 260 0.5× 625 1.5× 220 0.6× 140 0.8× 78 1.3k
C. William Wester United States 27 1.5k 1.3× 651 1.3× 892 2.1× 449 1.3× 287 1.6× 84 2.1k
Charles Kilewo Tanzania 19 908 0.8× 247 0.5× 510 1.2× 591 1.7× 161 0.9× 46 1.4k
R. J. Simonds United States 16 1.3k 1.1× 558 1.1× 675 1.6× 464 1.3× 248 1.4× 23 1.5k
George Kafulafula Malawi 20 792 0.7× 291 0.6× 493 1.1× 364 1.0× 196 1.1× 32 1.3k
Elisabeth Szumilin France 23 1.6k 1.4× 743 1.5× 706 1.6× 278 0.8× 316 1.8× 48 1.8k
François Dabis France 16 949 0.9× 448 0.9× 490 1.1× 280 0.8× 199 1.1× 25 1.1k

Countries citing papers authored by Joseph Makhema

Since Specialization
Citations

This map shows the geographic impact of Joseph Makhema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Makhema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Makhema more than expected).

Fields of papers citing papers by Joseph Makhema

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Makhema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Makhema. The network helps show where Joseph Makhema may publish in the future.

Co-authorship network of co-authors of Joseph Makhema

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Makhema. A scholar is included among the top collaborators of Joseph Makhema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Makhema. Joseph Makhema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ajibola, Gbolahan, Terence Mohammed, Sikhulile Moyo, et al.. (2025). Predictive Markers for Sustained Viral Suppression on Dual Broadly Neutralizing Antibodies During Antiretroviral Treatment Interruption in Children. JAIDS Journal of Acquired Immune Deficiency Syndromes. 99(3). 293–299. 1 indexed citations
3.
4.
Choga, Wonderful T., Tendani Gaolathe, Joseph Makhema, et al.. (2024). Hepatitis Delta Virus Clade 8 Is the Predominant Clade Circulating in Botswana amongst People Living with HIV. Viruses. 16(10). 1568–1568.
5.
Cui, Yifan, Sikhulile Moyo, Molly Pretorius Holme, et al.. (2024). Predictors of HIV seroconversion in Botswana. AIDS. 39(3). 290–297.
6.
Marukutira, Tafireyi, Nick Scott, Sherrie L. Kelly, et al.. (2020). Modelling the impact of migrants on the success of the HIV care and treatment program in Botswana. PLoS ONE. 15(1). e0226422–e0226422. 5 indexed citations
7.
Lebelonyane, Refeletswe, Pamela Bachanas, Lisa Block, et al.. (2020). Rapid antiretroviral therapy initiation in the Botswana Combination Prevention Project: a quasi-experimental before and after study. The Lancet HIV. 7(8). e545–e553. 24 indexed citations
8.
Chakalisa, Unoda, Kathleen E. Wirth, Kara Bennett, et al.. (2019). Self-reported risky sexual practices among adolescents and young adults in Botswana. Southern African Journal of HIV Medicine. 20(1). 899–899. 2 indexed citations
9.
Novitsky, Vladimir, Mélanie Prague, Sikhulile Moyo, et al.. (2017). High HIV-1 RNA Among Newly Diagnosed People in Botswana. AIDS Research and Human Retroviruses. 34(3). 300–306.
10.
Xie, Wen, Denis Agniel, Marianna K. Baum, et al.. (2017). Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa. AIDS Research and Human Retroviruses. 33(6). 597–609. 11 indexed citations
11.
Wilson, Ethan, Estelle Piwowar‐Manning, Marybeth McCauley, et al.. (2017). Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052. PLoS ONE. 12(5). e0177281–e0177281. 2 indexed citations
12.
Moyo, Sikhulile, Eduan Wilkinson, Alain Vandormael, et al.. (2017). Pairwise diversity and tMRCA as potential markers for HIV infection recency. Medicine. 96(6). e6041–e6041. 2 indexed citations
13.
Moyo, Sikhulile, Terence Mohammed, Lucy Mupfumi, et al.. (2016). Short Communication: Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana. AIDS Research and Human Retroviruses. 33(1). 17–18. 4 indexed citations
14.
Campa, Adriana, Sabrina Sales Martínez, Hermann Bussmann, et al.. (2014). Zinc deficiency facilitates disease progression in early HIV infected adults in Botswana (804.26). The FASEB Journal. 28(S1). 1 indexed citations
15.
Dryden‐Peterson, Scott, Michael D. Hughes, Haruna Jibril, et al.. (2011). Highly Active Antiretroviral Therapy Versus Zidovudine for Prevention of Mother-to-Child Transmission in a Programmatic Setting, Botswana. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(3). 353–357. 13 indexed citations
16.
Chen, Jennifer Y., Anthony Ogwu, Shahin Lockman, et al.. (2010). Antiretroviral Treatment Initiation Among HIV-Infected Pregnant Women with Low CD4+ Cell Counts in Gaborone, Botswana. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(1). 102–106. 19 indexed citations
17.
Rowley, Christopher F., Ibou Thior, C. William Wester, et al.. (2010). Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART. Journal of Clinical Virology. 48(3). 162–167. 29 indexed citations
18.
Lingappa, Jairam R., Barrot H. Lambdin, Kenneth Ngure, et al.. (2008). Regional Differences in Prevalence of HIV-1 Discordance in Africa and Enrollment of HIV-1 Discordant Couples into an HIV-1 Prevention Trial. PLoS ONE. 3(1). e1411–e1411. 126 indexed citations
19.
Shapiro, Roger, Laura Smeaton, Shahin Lockman, et al.. (2008). Risk Factors for Early and Late Transmission of HIV via Breast‐Feeding among Infants Born to HIV‐Infected Women in a Randomized Clinical Trial in Botswana. The Journal of Infectious Diseases. 199(3). 414–418. 15 indexed citations
20.
Bussmann, Hermann, C. William Wester, Carolyn Wester, et al.. (2007). Pregnancy Rates and Birth Outcomes Among Women on Efavirenz-Containing Highly Active Antiretroviral Therapy in Botswana. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(3). 269–273. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathleen Ragland Breakdown of academic impact, for papers by Karl‐Günter Technau Breakdown of academic impact, for papers by Ida Viho Breakdown of academic impact, for papers by John Idoko Breakdown of academic impact, for papers by C. William Wester Breakdown of academic impact, for papers by Charles Kilewo Breakdown of academic impact, for papers by R. J. Simonds Breakdown of academic impact, for papers by George Kafulafula Breakdown of academic impact, for papers by Elisabeth Szumilin Breakdown of academic impact, for papers by François Dabis
Rankless by CCL
2026